🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This partially randomized phase Ib/II trial studies the side effects and be...
Status
Terminated
Location
University of Alabama, Birmingham
Start Date
2015-06
Trial ID
NCT02457910
Treatments Being Tested
This international, multicenter, randomized, double-blinded, placebo-contro...
Status
Terminated
Location
Arizona Oncology
Start Date
2015-04-09
Trial ID
NCT02340221
Treatments Being Tested
Part A: This is a phase Ib trial combining the CDK4/6 inhibitor palbociclib...
Status
Completed
Location
The Royal Marsden NHS Foundation Trust
Start Date
2015-03-25
Trial ID
NCT02389842
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
This research study is a way of gaining new knowledge about the combination...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2015-04-20
Trial ID
NCT02390427
Treatments Being Tested
This is a two-arm, randomized, double-blind, multicenter, pre-operative stu...
Status
Completed
Location
Breastlink Med Group Inc
Start Date
2014-11-12
Trial ID
NCT02273973
This screening and multi-sub-study randomized phase II/III trial will estab...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-07-08
Trial ID
NCT02154490
This phase II MATCH treatment trial identifies the effects of GDC-0032 (tas...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2016-02-25
Trial ID
NCT04439175
Treatments Being Tested
Segmental overgrowth disorders are rare conditions characterised by abnorma...
Status
Terminated
Location
CHU d'Angers
Start Date
2017-07-31
Trial ID
NCT03290092
Treatments Being Tested
This phase II trial studies how well taselisib (GDC-0032) works in treating...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-11
Trial ID
NCT02785913
Treatments Being Tested